This is a protocol for derivation of glial restricted precursor (GRP) cells from the spinal cord of E13 mouse fetuses. These cells are early precursors within the oligodendrocytic cell lineage. Recently, these cells have been studied as potential source for restorative therapies in white matter diseases. Periventricular leukomalacia (PVL) is the leading cause of non-genetic white matter disease in childhood and affects up to 50% of extremely premature infants. The data suggest a heightened susceptibility of the developing brain to hypoxia-ischemia, oxidative stress and excitotoxicity that selectively targets nascent white matter. Glial restricted precursors (GRP), oligodendrocyte progenitor cells (OPC) and immature oligodendrocytes (preOL) seem to be key players in the development of PVL and are the subject of continuing studies. Furthermore, previous studies have identified a subset of CNS tissue that has increased susceptibility to glutamate excitotoxicity as well as a developmental pattern to this susceptibility. Our laboratory is currently investigating the role of oligodendrocyte progenitors in PVL and use cells at the GRP stage of development. We utilize these derived GRP cells in several experimental paradigms to test their response to select stresses consistent with PVL. GRP cells can be manipulated in vitro into OPCs and preOL for transplantation experiments with mouse PVL models and in vitro models of PVL-like insults including hypoxia-ischemia. By using cultured cells and in vitro studies there would be reduced variability between experiments which facilitates interpretation of the data. Cultured cells also allows for enrichment of the GRP population while minimizing the impact of contaminating cells of non-GRP phenotype.
Introduction
In this protocol we show how to extract, select and plate glial restricted precursor (GRP) cells from the spinal cord of E13 mouse fetuses. These cells are early precursors within the oligodendrocytic and astrocytic cell lineages and are defined by their expression of A2B5. In the GRP medium supplemented with FGF-2, the A2B5+ GRPs will begin expressing the early oligodendrocytic lineage markers PDGFαR and NG2 1, 2 . These oligodendrocyte lineage cells pass through a series of distinct phenotypic stages, each of them characterized by morphological changes, as well as expression of markers to specific developmental stages.
These precursor cells are currently being studied as a potential source for cell-based therapeutic approaches in disorders of the central nervous system white matter, including multiple sclerosis, leukodystrophies and periventricular leukomalacia (PVL) 3, 4, 5, 6 . Studies using human brain derived oligodendrocyte lineage precursors have reported successful remyelination in brains of the shiverer mouse dysmyelination model as well as in demyelinated spinal cord rodent models 6, 7, 8, 9 . These glial precursor cells have also been used in studies of other white matter disease models such as spinal cord injury and amyotrophic lateral sclerosis In addition to the use of GRPs for cell replacement, the derivation of these cells from wild type and transgenic rodent models of white matter diseases allows further study into glial differentiation under normal and disease conditions in an in vitro setting. Previous publications show evidence of selective vulnerability of oligodendrocytic lineage precursor cells to various external stressors like maturation dependent glutamate excitotoxicity, oxidative stress, and select factors implicated in neuroinflammation 18, 19 . Our studies have focused on understanding the cellular and molecular mechanisms behind the development of these white matter injuries, evaluating the susceptibility of cells in the oligodendrocyte lineage spectrum to insult as well as analyzing putative therapeutic approaches.
Materials
All procedures involving animals conform to PHS policy and the JHU IACUC. All procedures should be performed in a laminar flow hood in order to maintain aseptic conditions. Commonly dissections are performed in a horizontal flow hood and in vitro work in a vertical flow hood. All media used cold during dissections. The mice used in our study are a wild type CD-1 strain and a transgenic GFP in a C57/BL6 background. One CD-1 mouse dam typically yields 10+ fetuses which are enough to seed 1-2 T25 flasks. Typically, two dams are sacrificed at a time and fetal spinal cords pooled and plated into 1 T25 flask per dam. Once cells have been derived they can be expanded and characterized in vitro for subsequent studies.
Preparation of Media and Flasks
• GRP stock medium is used as the Dissection medium: DMEM / F12 1:1 (Invitrogen) + B27 (50x; Invitrogen) N2 (100x; Invitrogen)
Supplements and Bovine Serum Albumin (BSA; 0.5% w/v).
• Dissociation medium: same as dissection medium.
• Culture medium : GRP stock medium + FGF-2 (10-20 ng/ml; Invitrogen) and heparin (1 μg/ml; Sigma).
• PLL/laminin coated 75 cm 2 or 25 cm 2 flasks (T75 or T25).
• Tissue culture flasks (75 cm 2 , Falcon) were coated with 15-20μg/ml Poly-L-lysine (PLL; Sigma) in distilled H 2 O, incubated at 37 °C for 1 hr then aspirated. Flasks are washed 1X with PBS then coated with 15-20 μg/ml Laminin (Sigma) in PBS at 37 °C for 1 hr, then aspirated and fresh PBS or media added until cells are ready to be plated. Following coating, flasks should never be allowed to dry but can be kept in PBS or media at 4 °C for brief periods before use.
Instruments and Other Material
• Petri dishes: 4 per dam: 3 Petri dishes for dissection (75 mm), a 20 mm dish for collecting the harvested spinal cords.
• Large scissors (43 mm Operating scissors, Roboz) and tissue Forceps for opening the dam s abdomen.
• Small scissor for dissecting the uterus and removing the fetuses (15 mm Micro Dissecting Scissors, Roboz).
• Micro Dissecting spring scissors (6 mm) to dissect the spinal cord of the fetuses.
• Micro Dissecting angled Forceps for anchoring the dam and fetal body during surgery and later removing the spinal cord once exposed.
• 40 or 70 micrometer cell strainer for removing cell debris before plating.
• 0.05% Trypsin prewarmed to 37 °C.
• 10 mg/ml DNAse 1 (Sigma), prepared as a 100x stock (1 g/ml).
• Bio-hazard bag for animal corpses.
• 15 and 50 ml centrifuge tubes for processing extracted spinal cords.
Determining Timed Pregnancy
Pregnant mouse dams are either ordered from commercial sources specifying delivery on embryonic day E12 or E13 of fetal development or pregnancy determined in-house. Briefly, two females are placed together with one male in the late afternoon and left overnight together. The next day the females are observed for the presence of the vaginally located mucus plug. The mucus plug is only an indication that mating occurred so animals are subsequently weighed daily to monitor rate of weight increase. The day the mucus plug is observed is defined as embryonic day one (E1).
Tissue Derivation
1. Work under a horizontal flow hood to maintain aseptic conditions. 2. Spray down the hood and working area with 70% ethanol. 3. Autoclave instruments or spray liberally with 70% ethanol. 4. Prepare instruments, media, and microscope for use. 5. Pour 20 ml of cold dissection medium into sterile Petri dish. 6. Anesthetize animal with chloral hydrate (500 mg/kg) administered intraperitoneally (IP) followed by cervical dislocation or decapitation. 7. Spray the abdominal area of dam with 70-90% ethanol (disinfection) 8. Open abdomen with large scissor and forceps.
1. In CD1 and C57/BL6 strains: Usually 8 to 14 fetuses will be inside the uterus. The number of fetuses is strain dependent.
9. Extract the mouse uterus including the pups and place in fresh cold dissection medium in a clean Petri dish to wash blood and tissue debris from fetus. 10. Extract each fetus from the uterine horn and separate them from the embryonic sac and placenta using the small scissors. Transfer the extracted fetuses into fresh dissection medium in a new Petri dish.
. While multiple sclerosis and vasculopathies are the leading cause of white matter disease in adults, periventricular leukomalacia associated with prematurity is the most common cause of white matter injury in the childhood population. In order to further delineate disease mechanisms further study of cells ofoligodendrocytic lineage, which are greatly affected by the perinatal insult, is required. GRPs were isolated from the rodent embryonic spinal cord and shown to be tripotential in nature, giving rise to oligodendrocytes and two distinct astrocyte populations, but do not differentiate into neurons 2, 25, 26 . Likewise,oligodendrocyte precursor cells (OPC) derived from rat optic nerve and late embryonic or early postnatal rat brain have been demonstrated to mature into functioning oligodendrocytes in the appropriate media conditions 27, 28 .Additionally, fetal or adult derived human OPC have been further manipulated into more mature oligodendrocyte phenotypes 29, 30 . GRP cells have been isolated from both the spinal cord of E13.5 rats and E12-13.5 in mice. In the rat differences have been reported between dorsal-and ventral-derived GRP cells in their response to conditions that promote generation of oligodendrocytes, or astrocytes with ventralderived GRPs exhibiting a greater propensity to differentiate into the more mature phenotypes 25, 26, 28 . This is may be due to the ventral to dorsal migration of the nascent GRP cells, which could be less receptive to the differentiation cues. Immunopanning allows for the subpopulation that expresses A2B5 to be isolated and collected for maintenance in culture.
Our mouse GRP cultures are derived from total spinal cord tissue that yields a heterogeneous, pooled population of cells from which GRP cells are selected by chemical (medium) and antibody based techniques. While our studies have utilized the spinal cord derived mouse GRP cells, it has more recently been reported the derivation of brain derived mouse oligodendrocyte progenitor cells that are also capable of developing into mature oligodendrocytes 31 . Here the derived cells are initially cultured as oligospheres that using the appropriate culture medium are manipulated into an enriched PDGFαR+, OPC population 31 . Our studies have focused on the effect of our model of hypoxic-ischemic insult on cells in the oligodendrocyte lineage spectrum from A2B5+, PDGFαR-GRP precursors to the myelin basic protein expressing (MBP+) mature oligodendrocytes. Indeed our in vitro characterization has shown these immature GRP cells mature into MBP expressing cells either in monocultures or in co-cultures with cortical neurons. These cells can be manipulated in culture into specific differentiation pathways for studying the mechanisms involved in perinatal white matter injury. There are several mouse models of white matter diseases involving cells of oligodendrocyte lineage and the availability of this population allows for thorough investigation into the mechanisms that cause injury as well as to explore the usefulness of possible cell therapy options. 
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